Prognostic impact of left ventricular ejection fraction recovery in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention : analysis of an 11-year all-comers registry
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissionsoup.com..
AIMS: Left ventricular ejection fraction (LVEF) recovery after an ST-segment elevation myocardial infarction (STEMI) identifies a group of patients with a better prognosis. However, the association between long-term outcomes and LVEF recovery among patients with STEMI undergoing primary percutaneous coronary intervention (PCI) has not yet been well investigated. Our study aims to detect differences in long-term all-cause and cardiovascular mortality between patients who recover LVEF at 1-year post-PCI and those who do not, and search for predictors of LVEF recovery.
METHODS AND RESULTS: This is a retrospective, single-centre study of 2170 consecutive patients admitted for STEMI in which primary PCI is performed. LVEF was determined at admission and at 1-year follow-up. The primary outcomes were long-term all-cause and cardiovascular mortality. Among the 2168 patients with baseline LVEF data, 822 (38%) had a LVEF < 50% and 1346 (62%) ≥ 50%. Among those with LVEF < 50%, LVEF data at 1-year were available in 554, and 299 (54.0%) presented with complete recovery (LVEF ≥ 50%). LVEF recovery was associated with a reduction in long-term all-cause and cardiovascular mortality (P < 0.0001). Female sex, treatment with ACEIs, lower creatinine levels, infarct-related artery different from the left main or left anterior descendent artery, and absence of prior ischaemic heart disease were independently associated with LVEF recovery.
CONCLUSIONS: Nearly 40% of patients with STEMI undergoing primary PCI presented with LVEF depression at hospital admission. Among them, LVEF recovery at 1-year occurred in more than 50% and was independently associated with a significant decrease in long-term all-cause and cardiovascular mortality.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
European heart journal. Acute cardiovascular care - 10(2021), 8 vom: 27. Okt., Seite 898-908 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Otero-García, Oscar [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 24.11.2021 Date Revised 24.11.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/ehjacc/zuab058 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM328721344 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM328721344 | ||
003 | DE-627 | ||
005 | 20231225203537.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/ehjacc/zuab058 |2 doi | |
028 | 5 | 2 | |a pubmed24n1095.xml |
035 | |a (DE-627)NLM328721344 | ||
035 | |a (NLM)34327531 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Otero-García, Oscar |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prognostic impact of left ventricular ejection fraction recovery in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention |b analysis of an 11-year all-comers registry |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.11.2021 | ||
500 | |a Date Revised 24.11.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissionsoup.com. | ||
520 | |a AIMS: Left ventricular ejection fraction (LVEF) recovery after an ST-segment elevation myocardial infarction (STEMI) identifies a group of patients with a better prognosis. However, the association between long-term outcomes and LVEF recovery among patients with STEMI undergoing primary percutaneous coronary intervention (PCI) has not yet been well investigated. Our study aims to detect differences in long-term all-cause and cardiovascular mortality between patients who recover LVEF at 1-year post-PCI and those who do not, and search for predictors of LVEF recovery | ||
520 | |a METHODS AND RESULTS: This is a retrospective, single-centre study of 2170 consecutive patients admitted for STEMI in which primary PCI is performed. LVEF was determined at admission and at 1-year follow-up. The primary outcomes were long-term all-cause and cardiovascular mortality. Among the 2168 patients with baseline LVEF data, 822 (38%) had a LVEF < 50% and 1346 (62%) ≥ 50%. Among those with LVEF < 50%, LVEF data at 1-year were available in 554, and 299 (54.0%) presented with complete recovery (LVEF ≥ 50%). LVEF recovery was associated with a reduction in long-term all-cause and cardiovascular mortality (P < 0.0001). Female sex, treatment with ACEIs, lower creatinine levels, infarct-related artery different from the left main or left anterior descendent artery, and absence of prior ischaemic heart disease were independently associated with LVEF recovery | ||
520 | |a CONCLUSIONS: Nearly 40% of patients with STEMI undergoing primary PCI presented with LVEF depression at hospital admission. Among them, LVEF recovery at 1-year occurred in more than 50% and was independently associated with a significant decrease in long-term all-cause and cardiovascular mortality | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Left ventricular ejection fraction recovery | |
650 | 4 | |a Primary percutaneous coronary intervention | |
650 | 4 | |a Prognosis | |
650 | 4 | |a ST-segment elevation myocardial infarction | |
700 | 1 | |a Cid-Álvarez, Ana Belén |e verfasserin |4 aut | |
700 | 1 | |a Juskova, Mària |e verfasserin |4 aut | |
700 | 1 | |a Álvarez-Álvarez, Belén |e verfasserin |4 aut | |
700 | 1 | |a Tasende-Rey, Pablo |e verfasserin |4 aut | |
700 | 1 | |a Gude-Sampedro, Francisco |e verfasserin |4 aut | |
700 | 1 | |a García-Acuña, José María |e verfasserin |4 aut | |
700 | 1 | |a Agra-Bermejo, Rosa |e verfasserin |4 aut | |
700 | 1 | |a López-Otero, Diego |e verfasserin |4 aut | |
700 | 1 | |a Sanmartín-Pena, Juan Carlos |e verfasserin |4 aut | |
700 | 1 | |a Martínez-Monzonís, Amparo |e verfasserin |4 aut | |
700 | 1 | |a Trillo-Nouche, Ramiro |e verfasserin |4 aut | |
700 | 1 | |a González-Juanatey, José R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European heart journal. Acute cardiovascular care |d 2012 |g 10(2021), 8 vom: 27. Okt., Seite 898-908 |w (DE-627)NLM230912656 |x 2048-8734 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2021 |g number:8 |g day:27 |g month:10 |g pages:898-908 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/ehjacc/zuab058 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2021 |e 8 |b 27 |c 10 |h 898-908 |